PMC:7195088 / 10463-10932
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 172 | 129-137 | Species | denotes | patients | Tax:9606 |
| 205 | 60-71 | Chemical | denotes | tocilizumab | MESH:C502936 |
| 245 | 101-109 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T54 | 101-109 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T33 | 30-31 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T34 | 47-52 | http://purl.obolibrary.org/obo/CLO_0007225 | denotes | label |
| T35 | 198-199 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T36 | 204-208 | http://purl.obolibrary.org/obo/CLO_0008416 | denotes | peer |
| T37 | 204-208 | http://purl.obolibrary.org/obo/CLO_0050081 | denotes | peer |
| T38 | 338-339 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T46 | 47-52 | Chemical | denotes | label | http://purl.obolibrary.org/obo/CHEBI_35209 |
| T47 | 60-71 | Chemical | denotes | tocilizumab | http://purl.obolibrary.org/obo/CHEBI_64360 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T71 | 0-469 | Sentence | denotes | In our opinion, this could be a reasonable off-label use of tocilizumab in these early phases of the COVID-19 pandemic, although patients and physicians should be aware that currently there is only a non–peer-reviewed, noncomparative, observational experience (very low evidence from an unreviewed cases series) and that it only supports a potential favourable effect on inflammatory signs and symptoms, while there is no information on any possible effect on survival. |